NeurologyLive® Staff

Articles by NeurologyLive® Staff

Confounding Outcomes in Alzheimer, AFib and Dementia Risk, Cognitive Issues in Epilepsy, and MRI Imaging

ByNeurologyLive® Staff

November 10th 2018

Neurology News Network for the week of November 10, 2018.

Sodium Oxybate Approved, ANAVEX 2-73 Shows Positive Results, Ubrogepant for Acute Migraine Care, and Stroke Risk with Migraine

ByNeurologyLive® Staff

November 3rd 2018

Neurology News Network for the week of November 3, 2018.

Novel Deep Brain Stimulation System, ITI-214 Safe for Parkinson Disease, Elizabeth Ross on the Field's Progress

ByNeurologyLive® Staff

October 27th 2018

Neurology News Network for the week of Oct. 27, 2018.

New Alzheimer Association AUC, Patisiran Findings from AANEM, Evobrutinib findings from ECTRIMS

ByNeurologyLive® Staff

October 20th 2018

Neurology News Network for the week of October 20, 2018.

Siponimod NDA Accepted, New Appropriate Use Criteria for Alzheimer Disease Diagnosis, Disease-Modifying Therapy

ByNeurologyLive® Staff

October 13th 2018

Neurology News Network for the week of Oct. 12, 2018.

Never Events Common in Parkinson, Donepezil Fails to Prevent Psychosis, Helping Patients Live Well

ByNeurologyLive® Staff

October 6th 2018

Neurology News Network for the week of October 6, 2018.

Galcanezumab Approved, Pimavanserin Safety Confirmed, Treating Augmentation in RLS, Genetics in Alzheimer

ByNeurologyLive® Staff

September 29th 2018

Neurology News Network for the week of September 28, 2018.

FDA Approves Fremanezumab, Behavioral Activation Therapy for MCI, Choosing DMTs for MS

ByNeurologyLive® Staff

September 22nd 2018

Neurology News Network for the week of September 22, 2018.

XEN496 for KCNQ2 Epileptic Encephalopathy, the State of Acute Stroke Care, and Ocrelizumab's Success

ByNeurologyLive® Staff

September 15th 2018

Neurology News Network for the week of September 15, 2018.

NeurologyLive® Staff

Articles by NeurologyLive® Staff

Confounding Outcomes in Alzheimer, AFib and Dementia Risk, Cognitive Issues in Epilepsy, and MRI Imaging

Sodium Oxybate Approved, ANAVEX 2-73 Shows Positive Results, Ubrogepant for Acute Migraine Care, and Stroke Risk with Migraine

Novel Deep Brain Stimulation System, ITI-214 Safe for Parkinson Disease, Elizabeth Ross on the Field's Progress

New Alzheimer Association AUC, Patisiran Findings from AANEM, Evobrutinib findings from ECTRIMS

Siponimod NDA Accepted, New Appropriate Use Criteria for Alzheimer Disease Diagnosis, Disease-Modifying Therapy

Never Events Common in Parkinson, Donepezil Fails to Prevent Psychosis, Helping Patients Live Well

Galcanezumab Approved, Pimavanserin Safety Confirmed, Treating Augmentation in RLS, Genetics in Alzheimer

FDA Approves Fremanezumab, Behavioral Activation Therapy for MCI, Choosing DMTs for MS

XEN496 for KCNQ2 Epileptic Encephalopathy, the State of Acute Stroke Care, and Ocrelizumab's Success

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Inside the Development of ISSCR’s New Parkinson Disease Stem Cell Program

Mapping the Clinical Trial Landscape for Stem Cell Therapies in Parkinson Disease

What Clinicians Need to Know About Emerging Stem Cell Therapies for Parkinson Disease

Atogepant Gains European Approval as Acute and Preventive Migraine Therapy

Refining Myelitis Criteria to Reduce Misdiagnosis and Improve Care in Clinical Practice